Zealand Pharma AS (ZLDPF)
135.65
+2.24
(+1.68%)
USD |
OTCM |
Sep 20, 16:00
Zealand Pharma Total Assets (Quarterly): 1.458B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.458B |
| March 31, 2024 | 518.85M |
| December 31, 2023 | 293.97M |
| September 30, 2023 | 308.11M |
| June 30, 2023 | 299.11M |
| March 31, 2023 | 196.23M |
| December 31, 2022 | 221.62M |
| September 30, 2022 | 144.28M |
| June 30, 2022 | 176.42M |
| March 31, 2022 | 275.72M |
| December 31, 2021 | 314.77M |
| September 30, 2021 | 259.09M |
| June 30, 2021 | 307.93M |
| March 31, 2021 | 342.00M |
| December 31, 2020 | 291.22M |
| September 30, 2020 | 324.67M |
| June 30, 2020 | 342.71M |
| March 31, 2020 | 230.63M |
| December 31, 2019 | 231.01M |
| September 30, 2019 | 251.11M |
| June 30, 2019 | 187.29M |
| March 31, 2019 | 202.96M |
| December 31, 2018 | 188.39M |
| September 30, 2018 | 236.97M |
| June 30, 2018 | 80.99M |
| Date | Value |
|---|---|
| March 31, 2018 | 102.58M |
| December 31, 2017 | 116.24M |
| September 30, 2017 | 131.16M |
| June 30, 2017 | 58.62M |
| March 31, 2017 | 68.12M |
| December 31, 2016 | 98.78M |
| September 30, 2016 | 85.74M |
| June 30, 2016 | 71.39M |
| March 31, 2016 | 81.33M |
| December 31, 2015 | 93.19M |
| September 30, 2015 | 80.81M |
| June 30, 2015 | 77.69M |
| March 31, 2015 | 82.52M |
| December 31, 2014 | 97.43M |
| September 30, 2014 | 60.99M |
| June 30, 2014 | 60.94M |
| March 31, 2014 | 70.28M |
| December 31, 2013 | 64.21M |
| September 30, 2013 | 69.81M |
| June 30, 2013 | 75.61M |
| March 31, 2013 | 80.94M |
| December 31, 2012 | 92.59M |
| September 30, 2012 | 97.67M |
| June 30, 2012 | 93.51M |
| March 31, 2012 | 99.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
144.28M
Minimum
Sep 2022
1.458B
Maximum
Jun 2024
339.37M
Average
292.60M
Median
Total Assets (Quarterly) Benchmarks
| Novo Nordisk AS | 53.03B |
| Eli Lilly and Co | 71.87B |
| Altimmune Inc | 173.35M |
| Genmab AS | 5.544B |
| Viking Therapeutics Inc | 946.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 109.03M |
| Shareholders Equity (Quarterly) | 1.349B |
| Debt to Equity Ratio | 0.0295 |
| Current Ratio | 35.57 |
| Net Debt Paydown Yield | 0.04% |